Affordable Access

deepdyve-link
Publisher Website

Indirect Immune Recognition of Mouse Embryonic Stem Cell-Derived Hematopoietic Progenitors In Vitro

Authors
  • Thompson, Heather L.
  • McLelland, Bryce T.
  • Manilay, Jennifer O.1, 2, 3, 4, 2
  • 1 Quantitative and Systems Biology Graduate Program
  • 2 University of California
  • 3 Molecular and Cell Biology Unit
  • 4 School of Natural Sciences
Type
Published Article
Journal
Experimental Hematology
Publisher
Elsevier
Publication Date
Jan 01, 2014
Accepted Date
Jan 02, 2014
Identifiers
DOI: 10.1016/j.exphem.2014.01.003
Source
Elsevier
Keywords
License
Unknown

Abstract

The clinical use of embryonic stem cell (ESC)-derived hematopoietic progenitors (ESHPs) requires the generation of ESHPs that produce mature hematopoietic cells and do not induce immune rejection after transplantation. We compared the developmental maturity and immunogenicity of ESHPs generated via two methods: embryoid body (EB) formation and culture of ESCs with the OP9 bone marrow stromal cell line (ESC-OP9). ESHPs derived from EBs displayed an immature hematopoietic phenotype and were devoid of immunogenicity marker expression. In contrast, ESHPs derived via ESC-OP9 displayed a mature phenotype and expressed high levels of some immunostimulatory molecules. ESHPs alone could not stimulate CD4+ T lymphocyte proliferation directly. However, preferential phagocytosis of ESHPs and T cell proliferation were observed in the presence of antigen-presenting cells, consistent with a model of indirect immune recognition of ESHPs. These results suggest that depletion of host CD4+ T lymphocytes or antigen-presenting cells may be necessary for successful ESHP transplantation.

Report this publication

Statistics

Seen <100 times